Asset Portfolio
Asset Portfolio
Asset Portfolio
Small Molecule
Small Molecule
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG1063
SG1063
Oncology
Oncology
FAK/SRC
FAK/SRC
IND Ready
IND Ready
SG1064
SG1064
Diabetes / Obesity
Diabetes / Obesity
GLP1
GLP1
Oran IND Ready
Oran IND Ready
SG1065
SG1065
IPF
IPF
Smoothened
Smoothened
IND Ready
IND Ready
SG1066
SG1066
Oncology
Oncology
KRAS G12D
KRAS G12D
Phase 1
Phase 1
SG1067
SG1067
Oncology
Oncology
Brain Penetrable BTK
Brain Penetrable BTK
Phase 2
Phase 2
SG1068
SG1068
Oncology
Oncology
Pan-KRAS
Pan-KRAS
Preclinical
Preclinical
SG1069
SG1069
Pain
Pain
Nav1.8
Nav1.8
Phase 1
Phase 1
SG1070
SG1070
Oncology
Oncology
BTK/IRAK4 Degrader
BTK/IRAK4 Degrader
Preclinical
Preclinical
SG1071
SG1071
Immunology
Immunology
TYK Degrader
TYK Degrader
Preclinical
Preclinical
Large Molecule
Large Molecule
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG2021
SG2021
Obesity
Obesity
GDF15
GDF15
IND Ready
IND Ready
SG2022
SG2022
Immunology
Immunology
TSLP Nanobody inhale
TSLP Nanobody inhale
Phase 1 in China
Phase 1 in China
SG2023
SG2023
Immunology
Immunology
IL-4Rα Nanobody inhale
IL-4Rα Nanobody inhale
Phase 1 in China
Phase 1 in China
SG2026
SG2026
Oncology
Oncology
GPRC5D binder
GPRC5D binder
Preclinical
Preclinical
SG2037
SG2037
Oncology/Immunology
Oncology/Immunology
CD20/CD3
CD20/CD3
Phase 1 in China
Phase 1 in China
SG2039
SG2039
Oncology/Immunology
Oncology/Immunology
CD19/CD3
CD19/CD3
Preclinical
Preclinical
SG2040
SG2040
Diabetes/Obesity
Diabetes/Obesity
GLP1/GIP
GLP1/GIP
Phase 1 in China
Phase 1 in China
SG2041
SG2041
Oncology/Immunology
Oncology/Immunology
CD38/CD3
CD38/CD3
Preclinical
Preclinical
SG2042
SG2042
Oncology
Oncology
CDH17
CDH17
Preclinical
Preclinical
ADC
ADC
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG5002
SG5002
Oncology
Oncology
Cldn18.2
Cldn18.2
Preclinical
Preclinical
Cell Therapy
Cell Therapy
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG6001
SG6001
Oncology
Oncology
GBM
GBM
IIT
IIT
SG6002
SG6002
Neuro
Neuro
Parkinson's
Parkinson's
Phase 1 in USA/China
Phase 1 in USA/China
Legal
© 2025 by Conexus Bio.
Legal
© 2025 by Conexus Bio.
Legal
© 2025 by Conexus Bio.